Shenzhen Hepalink Pharmaceutical Group , Ltd. Total Current Liabilities

Shenzhen Hepalink Pharmaceutical Group , Ltd. (SHEZF) currently reports a total current liabilities of $4B as of June 2026. That compares with $4.2B in the prior-year period — down 3.8% year over year. Use the charts on this page to explore Shenzhen Hepalink Pharmaceutical Group , Ltd.'s total current liabilities history and peer comparisons.

Shenzhen Hepalink Pharmaceutical Group , Ltd.'s total current liabilities decreased from $4.2B to $4B — a 3.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Shenzhen Hepalink Pharmaceutical Group , Ltd. reported $4B in total current liabilities as of June 2026. That compares with $4.2B in the prior-year period — down 3.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Shenzhen Hepalink Pharmaceutical Group , Ltd., and consider following SHEZF for alerts when major investors trade the stock.